TrustCore Financial Services’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

TrustCore Financial Services’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-232	Closed	-$8K	–	1188
2021 Q2	$8K	Buy	+232	New	+$5.91K	﹤0.01%	786
2020 Q4	–	Sell	-49	Closed	-$1K	–	977
2020 Q3	$1K	Hold	49	–	–	﹤0.01%	827
2020 Q2	$1K	Buy	+49	New	+$1.76K	﹤0.01%	862

TrustCore Financial Services's CNST Position: Q3 2021 in Review

TrustCore Financial Services sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 232 shares — an estimated $8K sold.

TrustCore Financial Services first reported a position in CNST in Q2 2020 and held it in 3 quarters. The position peaked at $8K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

TrustCore Financial Services reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
TrustCore Financial Services sold 232 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $8K.
TrustCore Financial Services first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2020 and held it in 3 quarters.
TrustCore Financial Services's Constellation Pharmaceuticals, Inc. position peaked at $8K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on TrustCore Financial Services's 13F filing for Q3 2021, filed 8 Nov 2021.